ZBIO logo

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 2023

Total Assets

$403.4 M(+101.8%)$200.0 M(+307.6%)$49.1 M(-28.1%)$68.2 M(-18.6%)$83.8 M

Current Assets

$393.8 M(+108.8%)$188.6 M(+375.0%)$39.7 M(-33.6%)$59.8 M(-22.0%)$76.7 M

Non Current Assets

$9.7 M(-15.0%)$11.4 M(+21.5%)$9.3 M(+11.6%)$8.4 M(+17.7%)$7.1 M

Total Liabilities

$44.0 M(-91.0%)$488.7 M(+62.1%)$301.5 M(+2.6%)$293.9 M(+2.8%)$286.0 M

Current Liabilities

$44.0 M(+12.5%)$39.1 M(+28.9%)$30.3 M(+30.4%)$23.3 M(+49.5%)$15.6 M

Long Term Liabilities

$0.0(-100.0%)$449.6 M(+65.8%)$271.2 M(+0.2%)$270.6 M(+0.1%)$270.5 M

Shareholders Equity

$359.4 M(+224.5%)-$288.8 M(-14.4%)-$252.5 M(-11.9%)-$225.7 M(-11.6%)-$202.2 M

Book Value

$359.4 M(+224.5%)-$288.8 M(-14.4%)-$252.5 M(-11.9%)-$225.7 M(-11.6%)-$202.2 M

Working Capital

$349.8 M(+134.0%)$149.5 M(+1495.1%)$9.4 M(-74.4%)$36.5 M(-40.2%)$61.1 M

Cash And Cash Equivalents

$360.0 M(+95.8%)$183.9 M(+395.1%)$37.2 M(-34.6%)$56.9 M(-21.4%)$72.3 M

Accounts Payable

$15.1 M(+80.5%)$8.4 M(-5.3%)$8.8 M(+63.6%)$5.4 M(+137.1%)$2.3 M

Accounts Receivable

-----

Short Term Debt

-----

Long Term Debt

$0.0(-100.0%)$14.0 K(-99.9%)$21.1 M(+2.8%)$20.6 M(+0.9%)$20.4 M

Total Debt

$384.0 K(-24.4%)$508.0 K(-97.7%)$21.6 M(+2.5%)$21.1 M(+0.7%)$21.0 M

Debt To Equity

0.0(0%)0.0(+100.0%)-0.1(0%)-0.1(+10.0%)-0.1

Current Ratio

8.9(+85.7%)4.8(+267.9%)1.3(-49.0%)2.6(-47.9%)4.9

Quick Ratio

-----

Inventory

-----

Retained Earnings

-$334.8 M(-13.0%)-$296.2 M(-14.7%)-$258.2 M(-12.1%)-$230.4 M(-11.9%)-$205.8 M

PB Ratio

-----

Income statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 2023

EPS

-$5.0--$0.7-$0.2

TTM EPS

-$5.7--$0.5-$0.2

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$50.0 M

TTM Revenue

$0.0(-100.0%)$50.0 M(0%)$50.0 M(0%)$50.0 M(0%)$50.0 M

Total Expenses

$41.0 M(+3.2%)$39.7 M(+44.0%)$27.6 M(+11.3%)$24.8 M(+72.4%)$14.4 M

Operating Expenses

$41.0 M(+3.2%)$39.7 M(+44.0%)$27.6 M(+11.3%)$24.8 M(+72.4%)$14.4 M

Cost Of Goods Sold

-----

TTM Cost Of Goods Sold

-----

Gross Profit

-----

TTM Gross Profit

-----

Gross Margin

-----

Operating Profit

-$41.0 M(-3.2%)-$39.7 M(-44.0%)-$27.6 M(-11.3%)-$24.8 M(-169.6%)$35.6 M

TTM Operating Profit

-$133.0 M(-135.8%)-$56.4 M(-237.3%)-$16.7 M(-254.3%)$10.8 M(-69.6%)$35.6 M

Operating Margin

-----

Net Income

-$38.6 M(-1.7%)-$38.0 M(-36.6%)-$27.8 M(-13.1%)-$24.6 M(-169.1%)$35.6 M

TTM Net Income

-$129.0 M(-135.5%)-$54.8 M(-226.3%)-$16.8 M(-252.3%)$11.0 M(-69.0%)$35.6 M

Net Margin

-----

EBIT

-$41.0 M(-3.2%)-$39.7 M(-44.0%)-$27.6 M(-11.3%)-$24.8 M(-169.6%)$35.6 M

TTM EBIT

-$133.0 M(-135.8%)-$56.4 M(-237.3%)-$16.7 M(-254.3%)$10.8 M(-69.6%)$35.6 M

EBITDA

-$40.9 M(-3.2%)-$39.7 M(-44.0%)-$27.5 M(-11.3%)-$24.7 M(-169.4%)$35.6 M

TTM EBITDA

-$132.9 M(-136.0%)-$56.3 M(-238.3%)-$16.6 M(-252.7%)$10.9 M(-69.4%)$35.6 M

Selling, General & Administrative Expenses

$7.5 M(+26.4%)$5.9 M(+19.5%)$4.9 M(+13.1%)$4.4 M(-13.2%)$5.0 M

TTM SG&A

$22.6 M(+12.0%)$20.2 M(+41.2%)$14.3 M(+52.6%)$9.4 M(+86.8%)$5.0 M

Depreciation And Amortization

$36.0 K(+2.9%)$35.0 K(+6.1%)$33.0 K(+10.0%)$30.0 K(+15.4%)$26.0 K

TTM D&A

$134.0 K(+8.1%)$124.0 K(+39.3%)$89.0 K(+58.9%)$56.0 K(+115.4%)$26.0 K

Interest Expense

-----

TTM Interest Expense

-----

Income Tax

-----

TTM Income Tax

-----

PE Ratio

-----

PS Ratio

-----

Cashflow statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 2023

Cash From Operations

-$31.1 M(-0.3%)-$31.0 M(-62.1%)-$19.1 M(-24.0%)-$15.4 M(-148.4%)$31.8 M

TTM CFO

-$96.5 M(-187.1%)-$33.6 M(-1165.6%)-$2.7 M(-116.2%)$16.4 M(-48.4%)$31.8 M

Cash From Investing

-$26.8 M(-76357.1%)-$35.0 K(-59.1%)-$22.0 K(-29.4%)-$17.0 K(-100.0%)$0.0

TTM CFI

-$26.8 M(-36162.2%)-$74.0 K(-89.7%)-$39.0 K(-129.4%)-$17.0 K(-100.0%)$0.0

Cash From Financing

$234.0 M(+31.6%)$177.7 M(+29047.7%)-$614.0 K(-1328.0%)$50.0 K(-99.8%)$20.0 M

TTM CFF

$411.2 M(+108.5%)$197.2 M(+914.5%)$19.4 M(-3.1%)$20.1 M(+0.3%)$20.0 M

Free Cash Flow

-$31.1 M(-0.2%)-$31.0 M(-62.1%)-$19.1 M(-24.0%)-$15.4 M(-148.4%)$31.8 M

TTM FCF

-$96.6 M(-186.7%)-$33.7 M(-1150.1%)-$2.7 M(-116.4%)$16.4 M(-48.4%)$31.8 M

CAPEX

-$35.0 K(+59.1%)$22.0 K--

TTM CAPEX

-$57.0 K(+159.1%)$22.0 K--

Dividends Paid

-----

TTM Dividends Paid

-----

TTM Dividend Per Share

-----

TTM Dividend Yield

-----

Payout Ratio

-----